Coreg Cr Capsule, Extended Release
Product Images NDC 80725-385

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Coreg Cr (NDC 80725-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Coreg 01)

FDA Label Image

Figure 1 (Coreg 02)

FDA Label Image

Figure 2 (Coreg 03)

This text appears to be a list of criteria or variables related to a medical study or evaluation. It mentions different categories such as gender (Men, Women), age (less than 85, equals 65), race (Non-black, Black), medical conditions (Diabetic, Non-diabetic, Ischemic, Nonischemic), heart rate (greater than 70, less than 70), medication (Spironolactone, No spironolactone), and a general mention of all patients (Al patients). The last part mentioning "Hazard ratio" and numbers (15, 20) is not clear.*

FDA Label Image

Figure 3 (Coreg 04)

FDA Label Image

Figure 4 (Coreg 05)

FDA Label Image

Figure 5 (Coreg 06)

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (40 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (80 mg Capsule Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.